Century Therapeutics Income Statement (2022-2025) | IPSC

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue	1.06M	1.40M	2.22M	0.52M	1.72M	0.10M	0.15M	0.27M	0.85M	0.77M	0.79M	4.17M	109.16M
Operating items
Amortization - Deferred Charges	0.08M	0.08M	0.08M		0.06M	0.04M
Research & Development	21.20M	24.49M	25.90M	25.59M	24.90M	22.73M	22.79M	22.30M	23.42M	27.22M	27.23M	29.38M	26.58M	26.86M	22.53M
Wages, Salaries and Other									9.76M	10.94M	11.06M	10.64M	9.98M	9.71M	8.34M
Selling, General & Administrative	7.30M	8.25M	8.06M	8.24M	8.90M	8.23M	8.99M	8.59M	8.74M	8.31M	8.35M	7.75M	8.41M	7.80M	6.83M
Other Operating Expenses	10.00M					1.72M	0.15M	13.14M			0.79M	4.17M			6.76M
Operating Expenses	38.49M	32.75M	33.96M	33.83M	33.80M	35.18M	35.77M	44.03M	32.16M	35.53M	35.58M	41.46M	34.99M	34.66M	36.12M
Operating Income	-37.44M	-31.35M	-31.74M	-33.31M	-32.08M	-35.08M	-35.63M	-43.76M	-31.31M	-34.76M	-34.79M	-37.28M	74.18M	-34.66M	-36.12M
EBIT	-37.44M	-31.35M	-31.74M	-33.31M	-32.08M	-35.08M	-35.63M	-43.76M	-31.31M	-34.76M	-34.79M	-37.28M	74.18M	-34.66M	-36.12M
Non-operating items
Interest & Investment Income		0.25M	1.41M		2.62M	3.06M	3.49M	3.51M	3.24M	3.58M	3.31M	2.88M	2.42M	2.01M	1.60M
Other Non Operating Income	0.25M	0.01M	-0.02M	4.44M	-0.19M	-0.19M	0.01M	-0.01M	0.01M	-0.01M	0.25M	0.11M	-0.04M	0.11M	0.10M
Non Operating Income	-0.06M	0.38M	1.01M	1.66M	2.02M	2.74M	3.50M	3.50M	3.25M	3.57M	3.56M	2.99M	2.38M	2.12M	1.70M
Net income details
EBT	-37.50M	-30.97M	-30.72M	-31.65M	-30.06M	-32.34M	-32.13M	-40.27M	-28.06M	-31.18M	-31.23M	-34.30M	76.56M	-32.54M	-34.42M
Tax Provisions	0.02M	0.02M	0.03M	0.03M	1.21M	0.95M	0.59M	-0.87M	0.00M	0.02M	-0.01M	1.78M
Profit After Tax	-37.51M	-30.99M	-30.75M	-31.68M	-31.26M	-33.29M	-32.72M	-39.40M	-28.06M	-31.21M	-31.23M	-36.07M	76.56M	-32.54M	-34.42M
Income from Continuing Operations	-37.51M	-30.99M	-30.75M	-31.68M	-31.26M	-33.29M	-32.72M	-39.40M	-28.06M	-31.21M	-31.23M	-36.07M	76.56M	-32.54M	-34.42M
Consolidated Net Income	-37.51M	-30.99M	-30.75M	-31.68M	-31.26M	-33.29M	-32.72M	-39.40M	-28.06M	-31.21M	-31.23M	-36.07M	76.56M	-32.54M	-34.42M
Income towards Parent Company	-37.51M	-30.99M	-30.75M	-31.68M	-31.26M	-33.29M	-32.72M	-39.40M	-28.06M	-31.21M	-31.23M	-36.07M	76.56M	-32.54M	-34.42M
Net Income towards Common Stockholders	-37.51M	-30.99M	-30.75M	-31.68M	-31.26M	-33.29M	-32.72M	-39.40M	-28.06M	-31.21M	-31.23M	-36.07M	76.56M	-32.54M	-34.42M
Additional items
EPS (Basic)	-0.66	-0.54	-0.53	-0.55	-0.53	-0.56	-0.55	-0.65	-0.45	-0.38	-0.37	-0.43	0.89	-0.38	-0.40
EPS (Weighted Average and Diluted)	-0.66	-0.54	-0.53	-1.24	-0.53	-0.56	-0.55	-0.65	-0.45	-0.38	-0.37	-0.43	0.89	-0.38	-0.40
Shares Outstanding (Weighted Average)	58.82M	58.85M	58.88M	58.97M	59.17M	59.58M	59.77M	59.83M	64.82M	82.85M	84.72M	85.03M	86.05M	86.16M	86.39M
Shares Outstanding (Diluted Average)	57.05M	57.69M	57.97M	32.39M	58.61M	59.25M	59.45M	59.31M	62.30M	82.09M	84.70M	78.65M	86.10M	86.24M	86.46M
EBITDA	-39.51M	-31.78M	-30.92M	-30.54M	-30.08M	-33.22M	-32.82M	-37.98M	-28.41M	-31.27M	-30.16M	-36.51M	76.54M	-32.76M	-34.44M
Interest Expenses	0.31M	0.33M	0.37M	0.41M	0.40M	0.14M
Shares Outstanding	57.59M	57.86M	58.18M	58.47M	59.11M	59.31M	59.51M	60.34M	64.81M	84.55M	84.76M	85.84M	86.15M	86.32M	86.53M
Tax Rate								2.15			0.03

Research Tools

Century Therapeutics Income Statement (2022-2025) | IPSC

Create an account

Sign In

Reset Password

Get Pro for 60% off